MARKET

MDCX

MDCX

Medicus Pharma Ltd
NASDAQ
3.290
-0.150
-4.36%
Closed 16:05 03/14 EDT
OPEN
3.490
PREV CLOSE
3.440
HIGH
3.500
LOW
3.160
VOLUME
27.85K
TURNOVER
3.50K
52 WEEK HIGH
6.00
52 WEEK LOW
1.740
MARKET CAP
39.23M
P/E (TTM)
-2.3688
1D
5D
1M
3M
1Y
5Y
1D
Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials
TipRanks · 6d ago
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
Newsfile · 6d ago
Weekly Report: what happened at MDCX last week (0303-0307)?
Weekly Report · 6d ago
Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating
TipRanks · 03/07 16:25
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
Newsfile · 03/07 01:30
Medicus Pharma announces positively trending interim analysis for SKNJCT-003
TipRanks · 03/06 12:36
MEDICUS PHARMA: PLANS TO SUBMIT ANALYSIS TO FDA UNDER PACKAGE SEEKING TYPE C MEETING WITH FDA IN Q2
Reuters · 03/06 12:30
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Newsfile · 03/06 12:30
More
About MDCX
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.

Webull offers Medicus Pharma Ltd stock information, including NASDAQ: MDCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDCX stock methods without spending real money on the virtual paper trading platform.